Guo Xinwei, Li Jingbo
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200233 Shanghai, China.
Rev Cardiovasc Med. 2024 Mar 1;25(3):81. doi: 10.31083/j.rcm2503081. eCollection 2024 Mar.
Atrial fibrillation (AF) is a common disease and is effectively managed through catheter ablation (CA). However, post-ablation AF recurrence can compromise patient outcomes, making the identification of associated risk factors crucially important. Factors influencing poor clinical outcomes include age, female sex, body mass index (BMI), non-paroxysmal AF, and comorbidities including diabetes mellitus (DM) and obstructive sleep apnea (OSA). Furthermore, the selected ablation strategy and employed technology are pivotal to long-term success in maintaining sinus rhythm control. The mechanisms of AF recurrence are complex and multifactorial; no single predictor is definitive. Thus, a personalized assessment of each patient should be tailored to the individual situation. A high risk of relapse does not preclude the option of ablation therapy, but rather underscores the necessity to address and manage underlying conditions contributing to AF pathogenesis, aiming to mitigate the risk of recurrence.
心房颤动(AF)是一种常见疾病,可通过导管消融术(CA)进行有效治疗。然而,消融术后房颤复发会影响患者的治疗效果,因此识别相关危险因素至关重要。影响临床预后不良的因素包括年龄、女性性别、体重指数(BMI)、非阵发性房颤以及合并症,如糖尿病(DM)和阻塞性睡眠呼吸暂停(OSA)。此外,所选的消融策略和使用的技术对于维持窦性心律控制的长期成功至关重要。房颤复发的机制复杂且多因素;没有单一的预测指标是确定的。因此,应根据个体情况对每位患者进行个性化评估。高复发风险并不排除消融治疗的选择,而是强调了应对和管理导致房颤发病的潜在疾病的必要性,旨在降低复发风险。